North America
The Prices of Ketoconazole experienced a fluctuating trajectory in the Fourth quarter of 2022, with CFR Houston values falling from $144850/mt to $144250/mt from Oct to Dec. In the fourth quarter of 2022, there were fluctuations in the North American Ketoconazole market. Prices began to climb in Q4 2022 and continued to do so throughout the second month of the fourth quarter due to high manufacturing costs, numerous logistical issues, and rising inflation. Additionally contributing to the market's stability were rising transportation costs and port congestion at the major ports. Additionally, the market benefited from confusion and a halt in API production as a result of higher energy prices. Later in December, prices started to fall as a result of declining inflation and dwindling end-user sector demand as the holiday season drew near.

Asia
The Ketoconazole Prices in the Asia Pacific region showed a favorable trend in China, where FOB Shanghai values accessed at $ 132250/mt FOB Shanghai. The Asia Pacific region experienced generally unchanged market sentiments for the Ketoconazole API during the fourth quarter of 2022. Due to strong demand from downstream pharmaceutical businesses, prices started to rise steadily at the beginning of the fourth quarter. Zero-covid policies and the installation of lockdowns both had an impact on the market environment. Later, in the second month, the ketoconazole prices got underway. Lower production costs, sufficient stockpiles, and a strong supply caused the Ketoconazole API price trajectory to exhibit a stable trend. The domestic market was also sustained by steady end-user demand.

Europe
The CFR Hamburg negotiations for Ketoconazole API in Germany decreased from $146410/mt to $145820/mt between Oct and Dec 2022, continuing a Stable trend that began in the Fourth quarter. During the fourth quarter of 2022, market sentiment for the Ketoconazole API in the European region remained largely stable. At the beginning of the fourth quarter, prices started to rise steadily as a result of the robust demand from downstream pharmaceutical businesses. The implementation of lockdown and zero-covid policies both had an effect on the European market environment. Later, beginning of the second month, ketoconazole prices started to get stabilized. The Ketoconazole API price trajectory showed a consistent trend due to lower production costs, ample inventories, and a robust supply. Consistent consumer demand also supported the local market.

ChemAnalyst addresses the key problematic areas and risks associated with chemical and petrochemical business globally and enables the decision-maker to make smart choices. It identifies and analyses factors such as geopolitical risks, environmental risks, raw material availability, supply chain functionality, disruption in technology and so on. It targets market volatility and ensures clients navigate through challenges and pitfalls in an efficient and agile manner. Timeliness and accuracy of data has been the core competency of ChemAnalyst, benefitting domestic as well as global industry in tuning in to the real-time data points to execute multi-billion-dollar projects globally.

https://www.chemanalyst.com/Pricing-data/ketoconazole-1508